The newly opened pharmaceutical company Ynnovas represents a project funded within the state’s Produce in Georgia program.
The project’s total investment amounted to 4 million 500 thousand dollars, according to Ynnovas’ head David Ebralidze.
Innova’s pharmaceutical plant is already operating in a testing mode, Ebralidze told CBW. The plant will fully operate in several weeks, he added.
According to Ebralidze, 90% of Innova’s products is export-oriented and neighboring countries such as Azerbaijan, Khazakhstan, Russia and Ukraine are already among potential clients.